Hepatitis C virus research
This cluster of papers focuses on the epidemiology, treatment, and outcomes of hepatitis C virus infection. It covers topics such as antiviral therapy, genetic variation in viral clearance, global epidemiology, liver-related mortality, immune responses, and the impact of comorbidities like HIV and diabetes.
Papers listed on taxonomy pages are the top few works per node from the OpenAlex snapshot. That list is not exhaustive and is not an endorsement. The topic map and the journal registry remain separate: there is still no authoritative topic-to-venue or topic-to-organization edge. Search is a lexical lookup, not a claim that a venue publishes a topic.
Most cited
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
- The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
- An Algorithm for the Grading of Activity in Chronic Hepatitis C
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
Most recent
- Clinical phenotypes and incidence of acute or recent hepatitis C virus infection and bacterial sexually transmitted infections among MSM with HIV
- Hepatitis C virus genotype distribution and its association with clinical and biochemical characteristics among patients with chronic liver disease in Western Uttar Pradesh, India
- From viral clearance to cancer prevention: the next phase of hepatitis elimination
- Impact of hepatitis C viremia on overall survival and hepatic decompensation among patients with unresectable HCC receiving immunotherapy
- Testing for Hepatitis C Virus in Perinatally Exposed Children
- Cost-Effectiveness of Improving Hepatitis C Diagnosis and Treatment among People Who Inject Drugs in Türkiye